Higher prevalence of depression was associated with current or previously received ART treatment or having a CD4 count < 350 cells/mm3 compared to never using ARTs and having a CD4 count > 350 cells/mm3 (Table 4). The gene discussed is CD4; the disease is depressive symptom measurement.